Orlando, Florida
Colorectal cancer clinical trials in Orlando, FL
23 colorectal cancer studies are recruiting participants at sites in Orlando as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Orlando at a glance
- 23 studies are recruiting at a site in Orlando.
- By phase: Phase 1 (4), Phase 1/2 (4), Phase 2 (3), Phase 2/3 (1), Phase 3 (6), No phase (5). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (19), university, hospital or other (4).
- Most recent update to one of these records: November 13, 2026.
Studies recruiting in Orlando
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses
- No phase
- Ages 22 and older
- All sexes
- Sponsor
- GI Windows, Inc.
- Study site
- Orlando Health
- Registry record
- NCT07276529 · updated
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Orlando Health Cancer Institute ( Site 0065)
- Registry record
- NCT06997497 · updated
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Orlando Health Cancer Institute
- Registry record
- NCT07750158 · updated
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Summit Therapeutics
- Registry record
- NCT07228832 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- AdventHealth East Orlando · AdventHealth Orlando · Orlando Health Cancer Institute
- Registry record
- NCT05174169 · updated
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- AdventHealth Medical Group Oncology and Hematology at Orlando
- Registry record
- NCT06662786 · updated
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- AdventHealth Cancer Institute
- Registry record
- NCT06750094 · updated
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Study site
- Sarah Cannon Research Institute (Lake Nona)
- Registry record
- NCT03526835 · updated
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- AdventHealth Orlando /ID# 270789
- Registry record
- NCT06820463 · updated
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Alterome Therapeutics, Inc.
- Registry record
- NCT06835569 · updated
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Sutro Biopharma, Inc.
- Study site
- SCRI at Florida Cancer Specialists
- Registry record
- NCT07807345 · updated
Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population
- No phase
- Ages 45 to 84
- All sexes
- Sponsor
- Jubaan Ltd.
- Study site
- Orlando Gastroenterology, PA
- Registry record
- NCT07623902 · updated
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Criterium, Inc.
- Study site
- Orlando Health Cancer Institute
- Registry record
- NCT06992258 · updated
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study site
- Florida Cancer Specialists
- Registry record
- NCT07186842 · updated
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- PMV Pharmaceuticals, Inc
- Study site
- Advent Health
- Registry record
- NCT04585750 · updated
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Study site
- Advent Health Medical Group Radiation Oncology at Central Florida
- Registry record
- NCT07020117 · updated
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Seagen, a wholly owned subsidiary of Pfizer
- Study sites
- Florida Cancer Specialists · Sarah Cannon Research Institute at Florida Cancer Specialists
- Registry record
- NCT06131840 · updated
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Study site
- Advent Health
- Registry record
- NCT06948448 · updated
Increasing Germline Genetic Testing for Patients With Cancer
- No phase
- All ages
- All sexes
- Sponsor
- Josh Peterson
- Study site
- Orlando VA Medical Center
- Registry record
- NCT07307664 · updated
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Rapamycin Holdings Inc.
- Study site
- Digestive & Liver Center of Florida
- Registry record
- NCT06950385 · updated
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Tasca Therapeutics
- Study site
- Florida Cancer Specialists-Lake Nona
- Registry record
- NCT07030257 · updated
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- AdventHealth Translational Research Institute
- Study site
- AdventHealth
- Registry record
- NCT05773144 · updated
Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- AdventHealth Translational Research Institute
- Study site
- AdventHealth
- Registry record
- NCT05789433 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Orlando, FL on ClinicalTrials.gov.
Ask about studies near Orlando
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
132 studies recruiting across 62 cities.
Tampa
41 studies recruiting.
Jacksonville
29 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections